Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 3 , Pages 201-206 , May 2006

Clinical symptoms in localized renal cell carcinoma reflect its invasive potential: Comparative study between incidentally detected and symptomatic diseases

  • Ken-ichi Harada, M.D.

      Affiliations

    • Department of Urology, Hyogo Medical Center for Adults, Akashi, Japan
    • ,
  • Iori Sakai, M.D.

      Affiliations

    • Department of Urology, Hyogo Medical Center for Adults, Akashi, Japan
    • ,
  • Takeshi Ishimura, M.D., Ph.D.

      Affiliations

    • Department of Urology, Hyogo Medical Center for Adults, Akashi, Japan
    • ,
  • Taka-aki Inoue, M.D., Ph.D.

      Affiliations

    • Department of Urology, Hyogo Medical Center for Adults, Akashi, Japan
    • ,
  • Isao Hara, M.D., Ph.D.

      Affiliations

    • Department of Urology, Kobe University School of Medicine, Kobe, Japan
    • ,
  • Hideaki Miyake, M.D., Ph.D.

      Affiliations

    • Department of Urology, Hyogo Medical Center for Adults, Akashi, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-78-929-1151; fax: +81-78-929-2380

Received 14 April 2005 ,Revised 6 July 2005 ,Accepted 7 July 2005.

References 

  1. Delahunt B , Kittelson JM , McCredie MR , et al.   Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma . Cancer . 2002;94:658–664
  2. Sweeney JP , Thornhill JA , Grainger R , et al.   Incidentally detected renal cell carcinoma (Pathological features, survival trends and implications for treatment) . Br J Urol . 1996;78:351–353
  3. Pantuck AL , Zisman A , Rauch MK , et al.   Incidental renal tumors . Urology . 2000;56:190–196
  4. Tsui KH , Shvarts O , Smith RB , et al.   Renal cell carcinoma (Prognostic significance of incidentally detected tumors) . J Urol . 2000;163:426–430
  5. Miyake H , Ishimura T , Sakai I , et al.   Clinicopathological features of incidentally detected renal cell carcinoma in Japan . UroOncology . 2003;3:95–98
  6. Ishimura T , Sakai I , Hara I , et al.   Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery . Int J Urol . 2004;11:264–268
  7. Stephenson AJ , Chetner MP , Rourke K , et al.   Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy . J Urol . 2004;172:58–62
  8. Zhang X , Takenaka I . Cell proliferation and apoptosis with bcl-2 expression in renal cell carcinoma . Urology . 2000;56:510–515
  9. Kallakury BV , Karikehalli S , Haholu A , et al.   Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma . Clin Cancer Res . 2001;7:3113–3119
  10. Slaton JW , Inoue K , Perrotte P , et al.   Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma . Am J Pathol . 2001;158:735–743
  11. Miyake H , Hara S , Arakawa S , et al.   Over expression of clusterin is an independent prognostic factor for non-papillary renal cell carcinoma . J Urol . 2002;167:703–706
  12. Uchida T , Gao JP , Wang C , et al.   Clinical significance of p53, mdm2 and bcl-2 proteins in renal cell carcinoma . Urology . 2002;59:615–620
  13. Visapaa H , Bui M , Huang Y , et al.   Correlation of Ki-67 and gelsolin expression to clinical outcome in renal cell carcinoma . Urology . 2003;61:845–850
  14. Itoi T , Yamana K , Bilim V , et al.   Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients . Br J Cancer . 2004;90:200–205
  15. Zellweger T , Miyake H , July LV , et al.   Chemosensitization of human renal cell cancer using antisense olignucleotides targeting the antiapoptotic gene clusterin . Neoplasia . 2001;3:360–367
  16. Miyake H , Hara I , Yoshimura K , et al.   Introduction of basic fibroblast growth factor gene into mouse renal cell carcinoma cell line enhances its metastatic potential . Cancer Res . 1996;56:2440–2445
  17. Miyake H , Hara I , Gohji K , et al.   Relative expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in mouse renal cell carcinoma cells regulates their metastatic potential . Clin Cancer Res . 1999;5:2824–2829

PII: S1078-1439(05)00174-2

doi: 10.1016/j.urolonc.2005.07.008

Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 3 , Pages 201-206 , May 2006

Article Tools

* Image Usage & Resolution